Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers
NCT02259933 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2014-10-09
Summary
Study to investigate safety, tolerability and pharmacokinetics of KUC 7483 CL after repeated dosing
Conditions
- Healthy
Interventions
- DRUG
-
KUC 7483 CL
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2004-05-31
More Related Trials
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
NCT04019743 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants
NCT04075409 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
NCT07219030 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants
NCT03501069 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics Study of CK-3773274
NCT04783766 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects
NCT01818232 ·Status: COMPLETED ·Phase: PHASE1
-
CC100: Safety and Tolerability of Single Doses
NCT02050334 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02753504 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of CXB909 in Healthy Male Subjects
NCT01505907 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
NCT02651753 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
NCT02259842 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Intravenous Ascorbic Acid
NCT01833351 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT05335044 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers
NCT02690961 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT04083846 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers
NCT04075643 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Dosing Study of IkT-148009.
NCT06641557 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
NCT01074710 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers
NCT01380223 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants
NCT06640920 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study With Colchicine in Healthy Volunteers
NCT01017003 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
NCT04478097 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects
NCT02264054 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants
NCT01106469 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet
NCT03804671 ·Status: COMPLETED ·Phase: PHASE1